ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Down 25.3% in May

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) was the target of a significant decline in short interest in May. As of May 15th, there was short interest totalling 12,100 shares, a decline of 25.3% from the April 30th total of 16,200 shares. Based on an average trading volume of 32,700 shares, the short-interest ratio is presently 0.4 days.

Institutional Trading of ProShares Ultra Nasdaq Biotechnology

Hedge funds have recently modified their holdings of the business. Texas Capital Bank Wealth Management Services Inc purchased a new position in shares of ProShares Ultra Nasdaq Biotechnology in the 1st quarter valued at about $288,000. Westwood Wealth Management purchased a new position in ProShares Ultra Nasdaq Biotechnology in the first quarter valued at about $575,000. Toth Financial Advisory Corp lifted its position in shares of ProShares Ultra Nasdaq Biotechnology by 132.3% during the 1st quarter. Toth Financial Advisory Corp now owns 26,111 shares of the exchange traded fund’s stock valued at $1,502,000 after acquiring an additional 14,870 shares during the period. Clarity Capital Partners LLC purchased a new stake in shares of ProShares Ultra Nasdaq Biotechnology during the 4th quarter worth approximately $201,000. Finally, IMC Chicago LLC acquired a new stake in shares of ProShares Ultra Nasdaq Biotechnology in the 4th quarter worth approximately $2,435,000.

ProShares Ultra Nasdaq Biotechnology Trading Up 0.9 %

Shares of ProShares Ultra Nasdaq Biotechnology stock traded up $0.48 on Friday, reaching $56.09. 8,151 shares of the stock were exchanged, compared to its average volume of 34,523. ProShares Ultra Nasdaq Biotechnology has a 1-year low of $40.10 and a 1-year high of $62.45. The business has a fifty day moving average price of $54.11 and a two-hundred day moving average price of $54.51.

ProShares Ultra Nasdaq Biotechnology Announces Dividend

The firm also recently announced a dividend, which was paid on Wednesday, March 27th. Shareholders of record on Thursday, March 21st were given a dividend of $0.0403 per share. The ex-dividend date was Wednesday, March 20th.

About ProShares Ultra Nasdaq Biotechnology

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.